Stocks and InvestingStocks and Investing
Fri, July 8, 2022
Thu, July 7, 2022
Wed, July 6, 2022
Tue, July 5, 2022

Vijay Kumar Maintained (ABT) at Buy with Decreased Target to $116 on, Jul 5th, 2022


Published on 2024-10-27 21:44:51 - WOPRAI, Vijay Kumar
  Print publication without navigation


Vijay Kumar of Evercore ISI Group, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $135 to $116 on, Jul 5th, 2022.

Vijay has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 1 agrees with Vijay's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022


These are the ratings of the 7 analyists that currently disagree with Vijay


  • Marie Thibault of "BTIG" Maintained at Strong Buy with Decreased Target to $130 on, Friday, June 24th, 2022
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $145 on, Tuesday, June 7th, 2022
  • Travis Steed of "B of A Securities" Maintained at Strong Buy and Held Target at $140 on, Tuesday, May 31st, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 17th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $135 on, Thursday, April 21st, 2022
  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $143 on, Thursday, April 21st, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022